MacroGenics
MGNX
#8650
Rank
S$0.33 B
Marketcap
S$5.26
Share price
1.23%
Change (1 day)
135.48%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): S-$1.99

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$1.95. In 2025 the company made an earnings per share (EPS) of S-$1.50 a decrease over its 2024 EPS that were of S-$1.36.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.9932.7%
2025S-$1.5010.28%
2024S-$1.36613.33%
2023S-$0.19-92.31%
2022S-$2.48-42.14%
2021S-$4.2936.44%
2020S-$3.15-21.84%
2019S-$4.02-24.58%
2018S-$5.34675.93%
2017S-$0.69-68.05%
2016S-$2.15168.25%
2015S-$0.80-55%
2014S-$1.783400%
2013S-$0.05094-108.68%
2012S$0.5924.49%
2011S$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.67-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$35.94-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.44-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.45-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.55-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.53-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.92 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA